James Simon

Summary

Publications

  1. doi request reprint Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder
    James A Simon
    Department of Obstetrics and Gynecology, George Washington University, Washington, DC 20036, USA
    Postgrad Med 122:128-36. 2010
  2. doi request reprint Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet
    James Simon
    Women s Health and Research Consultants, Washington, DC 20036, USA
    Obstet Gynecol 112:1053-60. 2008
  3. doi request reprint Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women
    James Simon
    The George Washington University School of Medicine, 1850 M Street NW, Suite 450, Washington, DC 20036, United States Electronic address
    Maturitas 77:274-81. 2014
  4. doi request reprint One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus
    James A Simon
    Women s Health and Research Consultants, The George Washington University School of Medicine, Washington, DC 20036, USA
    Menopause 20:418-27. 2013
  5. doi request reprint Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture
    James A Simon
    George Washington University, Washington DC, USA
    Menopause 20:130-7. 2013
  6. doi request reprint Are all bisphosphonates the same? Potential reasons for clinical differences: a perspective
    James A Simon
    Department of Obstetrics and Gynecology, George Washington University, School of Medicine, Washington, District of Columbia, USA
    J Womens Health (Larchmt) 19:719-27. 2010
  7. doi request reprint Endometrial safety of ultra-low-dose estradiol vaginal tablets
    James Simon
    Women s Health and Research Consultants, Washington, DC 20036, USA
    Obstet Gynecol 116:876-83. 2010
  8. doi request reprint Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen
    James A Simon
    George Washington University and Women s Health and Research Consultants, Washington, District of Columbia 20036, USA
    J Womens Health (Larchmt) 20:1453-65. 2011

Detail Information

Publications8

  1. doi request reprint Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder
    James A Simon
    Department of Obstetrics and Gynecology, George Washington University, Washington, DC 20036, USA
    Postgrad Med 122:128-36. 2010
    ..As our understanding of the pathophysiology of HSDD increases, it may become easier for physicians to identify and treat women with low sexual desire...
  2. doi request reprint Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet
    James Simon
    Women s Health and Research Consultants, Washington, DC 20036, USA
    Obstet Gynecol 112:1053-60. 2008
    ..To evaluate the efficacy of ultra-low-dose 10-microgram 17beta-estradiol (E2) vaginal tablets for treatment of vaginal atrophy...
  3. doi request reprint Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women
    James Simon
    The George Washington University School of Medicine, 1850 M Street NW, Suite 450, Washington, DC 20036, United States Electronic address
    Maturitas 77:274-81. 2014
    ..To examine the long-term safety of oral ospemifene, a non-estrogen tissue-selective estrogen agonist/antagonist, for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy (VVA) due to menopause...
  4. doi request reprint One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus
    James A Simon
    Women s Health and Research Consultants, The George Washington University School of Medicine, Washington, DC 20036, USA
    Menopause 20:418-27. 2013
    ..The aim of this study was to assess the safety of ospemifene, a novel selective estrogen receptor modulator, for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus...
  5. doi request reprint Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture
    James A Simon
    George Washington University, Washington DC, USA
    Menopause 20:130-7. 2013
    ....
  6. doi request reprint Are all bisphosphonates the same? Potential reasons for clinical differences: a perspective
    James A Simon
    Department of Obstetrics and Gynecology, George Washington University, School of Medicine, Washington, District of Columbia, USA
    J Womens Health (Larchmt) 19:719-27. 2010
    ..For the physician to optimally determine the bisphosphonate that best suits an individual patient, it is important that they are aware of the differences between them...
  7. doi request reprint Endometrial safety of ultra-low-dose estradiol vaginal tablets
    James Simon
    Women s Health and Research Consultants, Washington, DC 20036, USA
    Obstet Gynecol 116:876-83. 2010
    ..To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17β-estradiol vaginal tablets in postmenopausal women with vaginal atrophy...
  8. doi request reprint Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen
    James A Simon
    George Washington University and Women s Health and Research Consultants, Washington, District of Columbia 20036, USA
    J Womens Health (Larchmt) 20:1453-65. 2011
    ....